Legend Biotech Corporation (LEGN)
Nasdaq: LEGN · Pharmaceutical Preparations · Somerset, NJ · filing with the SEC since 2020
Who runs Legend Biotech Corporation
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Zhang Ingrid
Chief Executive Officer. First filing Sep 2026, latest Sep 16, 2026, 0 filings in all.
Officers reporting now
4
of 14 people with a filing in the last fifteen months
Directors reporting now
10
14 people on the record since 2026
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Santos Carlos E | Chief Financial Officer | Mar 2026 | Sep 23, 2026 | 1 · $0.00 |
| Zhang Ingrid | Chief Executive Officer | Sep 2026 | Sep 16, 2026 | none |
| Bash Alan | Interim CEO | Aug 2026 | Aug 18, 2026 | none |
| Huang Ying | Chief Executive Officer | Mar 2026 | Jul 2, 2026 | 2 · $200,000 |
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | director | Mar 2026 | Oct 1, 2026 | 1 · $300,000 |
| Casey Patrick John | director | Mar 2026 | Sep 28, 2026 | 1 · $100,000 |
| Heyman Tomas J. | director | Mar 2026 | Sep 28, 2026 | none |
| Ji Darren Xiaohui | director | Mar 2026 | Sep 28, 2026 | none |
| Mao Li | director | Mar 2026 | Sep 28, 2026 | none |
| Salovey Peter | director | Mar 2026 | Sep 28, 2026 | none |
| Kung Gareth | director | Mar 2026 | Mar 18, 2026 | none |
| Meng Robin | director | Mar 2026 | Mar 18, 2026 | none |
| Wang Ye | director | Mar 2026 | Mar 18, 2026 | none |
| Zhang Fangliang | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.